Genaissance Pharmaceuticals (GNSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genaissance Pharmaceuticals (GNSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (15)	3/24/2001 2:27:45 PM
From: jeanmarcel	Read Replies (1) of 183

Hello, My name is Jean-Marcel Staley and I just recently received some news about them from their Vice President of Public Affairs. It goes as follows. Our fundamentals remain very strong and we are truly a leader in our field: -We have already discovered proprietary HAP Markers for over 3,000 genes. -Our technology has been validated; we are the only company to demonstrate an ability to predict drug response using genomic markers. -An important partnership is in place with Janssen/Johnson & Johnson - a further validation of our technology and its potential. -Our analysts have reiterated their very positive outlook on Genaissance. Please let me know if I can help clarify any other issues. I figured I would keep other investors of GNSC informed as well. Later, Jean-Marcel Staley

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next